4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000099
SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $106.36 ($531,803)
- SVP, GEN COUNSEL & CORP SEC acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-11-05 | Option exercise 10b5-1 | +5,000 | $21.41 | $107,050 | 33,623 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-11-05 | Sale 10b5-1 | −788 | $104.80 | $82,582 | 32,835 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-11-05 | Sale 10b5-1 | −1,415 | $105.72 | $149,591 | 31,420 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-11-05 | Sale 10b5-1 | −1,524 | $106.82 | $162,788 | 29,896 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-11-05 | Sale 10b5-1 | −1,273 | $107.50 | $136,842 | 28,623 | D |
| Derivatives | |||||||
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-11-05 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 164,497 | D | ||
| Open-market sales · 5,000 sh · avg $106.36 · $531,803 | |||||||
Loading xslF345X05/wk-form4_1730927624.xml…